⌘K

Login Start Free

Home/Filings/4/0001628280-21-012387

4//SEC Filing

Billen Daniel 4

Accession 0001628280-21-012387

CIK 0001600620other

View on SEC.gov Company Profile

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 9:21 PM ET

Size

5.2 KB

Accession

0001628280-21-012387

Insider Transaction Report

Form 4

Period: 2021-06-14

Aurinia Pharmaceuticals Inc.AUPH

Director

Transactions

Award
Stock Option (right to buy)
2021-06-14+31,347→ 31,347 total
Exercise: $12.86Exp: 2031-06-14→ Common Shares (31,347 underlying)

Footnotes (1)

[F1]The option vests in twelve equal monthly installments commencing on July 14, 2021.

Documents

1 file

4
wf-form4_162389285746391.xmlPrimary
FORM 4

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1

filerCIK 0001837593

Filing Metadata

Form type: 4
Filed: Jun 15, 8:00 PM ET
Accepted: Jun 16, 9:21 PM ET
Size: 5.2 KB

View on SEC.gov